West Pharmaceutical Services Inc.
Janet Brutschea Haugen (Director) reports WST insider transactions
About this filing
West Pharmaceutical Services Inc. (WST) filed Form 4 (insider transaction) with the SEC on Oct 2, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Janet Brutschea Haugen · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | A · grantPhantom Stock UnitFootnotes F2 | +44 | $370.76 | $16,313.44 | 350.87 | Direct |
Footnotes
- F1 Reflects 791 shares of restricted stock units and dividend equivalents that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2 Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
More WST filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 10, 2026
- 4
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.